Definitive Contract HT942524C0064
Award Date
7/15/24
Potential Completion Date
1/1/25
Potential Value
$251K
Federal Agency
Defense Health Agency
Awardee
Avanti Polar Lipids, LLC
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
Q517 - Pharmacy Services
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Avanti Polar Lipids, LLC, a for-profit manufacturer of biological reagents, was issued by the National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH). The $12,998.93 firm fixed-price purchase order contract is for the provision of various lipid and chemical products, such as 3D-PHAD, cholesterol, and 25-hydroxycholesterol, in support of NIH research projects. Avanti Polar Lipids has a larger $1...
This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The award, valued at $5,448.91, was a firm fixed-price purchase order for Avanti Polar Lipids, LLC to provide various biological reagents, lipids, and other chemicals in support of medical and scientific research conducted by NICHD. The contract did not have any set-aside...
The U.S. Defense Logistics Agency (DLA) Troop Support Pacific awarded a Firm Fixed Price Delivery Order contract to Alfresa Corporation, a Japanese medical device and life sciences company, for the supply of laboratory reagents, diagnostic equipment, and consumable supplies to support U.S. military operations and medical treatment facilities in the Pacific region. The contract, with a ceiling value of $10,820.14, has an ultimate completion date of October 19, 2022. Alfresa Corporation is an...
The federal contract award is for the supply of a "PICCOLO LIPID PANEL PLUS" medical product to a U.S. government agency. The contract, valued at $1,220.00, was awarded to Abbott Laboratories Inc., a global healthcare company, on May 15, 2018. The contract has a period of performance through May 21, 2018 and is a firm fixed-price delivery order. The funding agency is the Defense Logistics Agency (DLA), an agency within the Department of Defense (DoD) that provides logistics,...
This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of specialized medical equipment and supplies. The contract is for the delivery of blood packs with anticoagulant, with a ceiling value of $3,303.84 and a completion date of August 18, 2025. Fenwal, Inc. is a registered vendor with the U.S. federal government, having maintained its registration since April 3, 2007, and has consistently secured...
This federal contract award, valued at $17,583.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4,568,108,400 vials of the medication AmBisome (50 mg), with a performance period ending on May 2, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a $3,404.64 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 50mg/25ml vials of the drug doxorubicin liposome, a chemotherapy medication. The award has a completion date of July 7, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a $7,903 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Sigma-Aldrich, Inc. (doing business as Sigma-Aldrich Sales, Inc.), a foreign-owned, for-profit organization. The contract is for the delivery of peptides, with a period of performance through May 20, 2016. Sigma-Aldrich has established itself as a key supplier of specialized laboratory...
This federal contract award, with ID SPE2DX15D3020|SPE2DX23FXHLN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,185.76 firm-fixed-price delivery order is for the supply of the pharmaceutical product LIVALO 2 MG TABLET 90S. The contract has an ultimate completion date of August 8, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
The federal contract award summarized here was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,482.42 firm fixed-price delivery order covers the supply of 4563490295 DOXORUBICIN LIPOSOME 20MG/10ML 10ML, with a performance period ending on January 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...